Clinical Trial

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-blind, placebo-controlled, multicenter clinical study. The main purpose of this study was to confirm the efficacy and safety of pirfenidone capsules in the treatment of pneumoconiosis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-03-16.
Status change: Not Yet Recruiting → Recruiting 2025-11-19
Trial Details
NCT Number NCT05288179
Lead Sponsor Beijing Continent Pharmaceutical Co, Ltd.
Conditions Pneumoconiosis
Enrollment 272 participants
Start Date 2022-06-07
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-24